News
Novartis breaks ground on San Diego biomedical R&D site
Novartis has started construction of a $1.1bn biomedical research centre in San Diego that will serve as the hub for its R&D operations.
R&D
Changing Faces: Pharma and biotech, January 2026
The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
News
Lilly strikes $8.8bn-plus alliance with China's Innovent
Eli Lilly has deepened its ties with Chinese biopharma company Innovent Biologics, signing a seventh R&D with a $350m upfront payment.
R&D
The long-delayed promise of the microbiome, with Sam Possemi...
Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
News
Bayer reveals data behind asundexian's stroke win
Bayer's oral Factor XIa inhibitor asundexian can reduce the risk of a secondary ischaemic stroke by 26%, according to the OCEANIC-STROKE trial.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
